Reversion algorithm for patients anticoagulated with dabigatran in urgent surgery
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:66 |
|---|---|
| Enthalten in: |
Revista espanola de anestesiologia y reanimacion - 66(2019), 3 vom: 01. März, Seite 149-156 |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Algoritmo de reversión para los pacientes anticoagulados con dabigatrán en cirugía urgente |
|---|
| Beteiligte Personen: |
Ferrandis, R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
97RWB5S1U6 |
|---|
| Anmerkungen: |
Date Completed 07.04.2020 Date Revised 27.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.redar.2018.09.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM290800102 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM290800102 | ||
| 003 | DE-627 | ||
| 005 | 20231225065511.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.redar.2018.09.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0969.xml |
| 035 | |a (DE-627)NLM290800102 | ||
| 035 | |a (NLM)30447895 | ||
| 035 | |a (PII)S0034-9356(18)30171-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ferrandis, R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reversion algorithm for patients anticoagulated with dabigatran in urgent surgery |
| 246 | 3 | 3 | |a Algoritmo de reversión para los pacientes anticoagulados con dabigatrán en cirugía urgente |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.04.2020 | ||
| 500 | |a Date Revised 27.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Antithrombins |2 NLM | |
| 650 | 7 | |a Factor Xa Inhibitors |2 NLM | |
| 650 | 7 | |a idarucizumab |2 NLM | |
| 650 | 7 | |a 97RWB5S1U6 |2 NLM | |
| 650 | 7 | |a Dabigatran |2 NLM | |
| 650 | 7 | |a I0VM4M70GC |2 NLM | |
| 700 | 1 | |a Colomina, M J |e verfasserin |4 aut | |
| 700 | 1 | |a Durán, L |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez-Luque, A |e verfasserin |4 aut | |
| 700 | 1 | |a Hidalgo, F |e verfasserin |4 aut | |
| 700 | 1 | |a Llau, J V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de anestesiologia y reanimacion |d 2012 |g 66(2019), 3 vom: 01. März, Seite 149-156 |w (DE-627)NLM222859482 |x 2341-1929 |7 nnns |
| 773 | 1 | 8 | |g volume:66 |g year:2019 |g number:3 |g day:01 |g month:03 |g pages:149-156 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.redar.2018.09.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 66 |j 2019 |e 3 |b 01 |c 03 |h 149-156 | ||